Phan P, Desai S, Garcia Elorio E, Greenfield D, Hinchcliff R, Iqbal U, et al. Embracing the use of artificial intelligence in scientific publishing. International Journal for Quality in Health Care. 2024;36(3).
Embracing the use of artificial intelligence in scientific publishing Ver más »
Paniagua A, Shelton R, Figueroa J, Guzman A, Gutierrez L, Hernández-Galdamez D, et al. Assessing the implementation of a multi-component hypertension program in a Guatemalan under-resourced dynamic context: an application of the RE-AIM/PRISM extension for sustainability and health equity. Implementation Science Communications. 2024;5.
Pan M, Beratarrechea A, Poggio R, He H, Chen CS, Chen J, et al. Identifying Who Benefits the Most from a Community Health Worker-Led Multicomponent Intervention for Hypertension. Int J Hypertens. 2024;2024:6311938.
NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027-50.
NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-93.
NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. Lancet. 2024;404(10455):851-63.
Kruk ME, Sabwa S, Lewis TP, Aniebo I, Arsenault C, Carai S, et al. Population assessment of health system performance in 16 countries. Bull World Health Organ. 2024;102(7):486-97b.
Population assessment of health system performance in 16 countries Ver más »
Kruk ME, Kapoor NR, Lewis TP, Arsenault C, Boutsikari EC, Breda J, et al. Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey. Lancet Glob Health. 2024;12(1):e100-e11.
Jameleddine M, Harzallah N, Grati H, Odabachian Jebali MC, Chemli J, García Martí S, et al. INEAS's Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. J Mark Access Health Policy. 2024;12(4):294-305.
Gulayin P, Gutierrez L, Pinto D, Fontana S, Ávila M, Gómez W, et al. A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2024;31.
